Profiling of rectal cancers MRI in pathological complete remission states after neoadjuvant concurrent chemoradiation therapy
Creators
- 1. Research Institute of Radiological Science, Yonsei University College of Medicine, Seoul 120-752 (Korea, Republic of)
- 2. Department of Radiology, Yonsei University College of Medicine, Seoul 120-752 (Korea, Republic of)
- 3. Department of Pathology, Yonsei University College of Medicine, Seoul 120-752 (Korea, Republic of)
- 4. Department of Radiation Oncology, Yonsei University College of Medicine, Seoul 120-752 (Korea, Republic of)
- 5. Department of Surgery, Yonsei University College of Medicine, Seoul 120-752 (Korea, Republic of)
Description
Aim: To fully characterise the magnetic resonance imaging (MRI) traits of rectal cancers in a large sample of patients, each experiencing pathological complete remission (pCR) after neoadjuvant concurrent chemoradiation therapy (CCRT). Materials and methods: A total of 120 patients (77 male, 43 female; median age, 59.5 years; range, 32–81 years) with rectal cancers in CCRT-induced pCR states who underwent pre- and post-CCRT MRI and eventual surgery between July, 2005 and September, 2014 were retrospectively reviewed. In most (n=100), diffusion-weighted imaging was also performed. Tumour volume, tumour regression grade (TRG), T-stage, mesorectal fascia (MRF) status, and T2 signal intensity (T2-SI) were analysed. Paired t-test and McNemar's test were applied for statistical comparisons. Results: Tumour volume declined sharply after CCRT (pre-CCRT, 21.5±22.4cm3; post-CCRT, 6.6±8.4cm3; p<0.001). TRG distribution was as follows: G1 (clinical CR), 3; G2, 38; G3, 78; G4, 1; and G5 (marked progression), 0. Downstaging of T-stage (34%,16/47) and MRF status (19.7%,13/66) did occur; but on post-CCRT MRI, 25.8% (31/120) remained at T3≥5 mm or T4 stage, and 44.2% (53/120) were MRF-positive. A majority (88.3%, 106/120) of patients displayed intermediate T2-SI prior to CCRT. Most converted to dark T2-SI after CCRT, with 12.5% (15/120) unchanged. On post-CCRT MRI, 11% (11/100) of patients showed diffusion restriction. Conclusion: MRI findings in CCRT-induced pCR-status rectal cancers were highly variable. Tumour volume and T2-SI mostly decreased; however, such lesions occasionally presented with unexpected atypical features, such as large residual volume and/or intermediate T2-SI. - Highlights: • MR findings of pCR-achieved rectal cancer after CCRT are highly variable. • The residual lesion of pCR-achieved rectal cancer often maintains large volume. • pCR lesions mostly show decreased T2 SI, but sometimes intermediate SI remain.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.crad.2015.11.011Additional details
Identifiers
- DOI
- 10.1016/j.crad.2015.11.011;
- PII
- S0009-9260(15)00448-1;
Publishing Information
- Journal Title
- Clinical Radiology
- Journal Volume
- 71
- Journal Issue
- 3
- Journal Page Range
- p. 250-257
- ISSN
- 0009-9260
- CODEN
- CLRAAG
INIS
- Country of Publication
- United Kingdom
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 48032774
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- BIOMEDICAL RADIOGRAPHY; FASCIA; NEOPLASMS; NMR IMAGING; PATIENTS; POLYMERASE CHAIN REACTION; RECTUM; REVIEWS; SURGERY
- Descriptors DEC
- ANIMAL TISSUES; BODY; CONNECTIVE TISSUE; DIAGNOSTIC TECHNIQUES; DIGESTIVE SYSTEM; DISEASES; DOCUMENT TYPES; GASTROINTESTINAL TRACT; GENE AMPLIFICATION; INTESTINES; LARGE INTESTINE; MEDICINE; NUCLEAR MEDICINE; ORGANS; RADIOLOGY
Optional Information
- Copyright
- Copyright (c) 2015 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.